Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ

Journal of Lipid Research

Volumn 41, Issue 1, 2000, Pages 75-83

  Panousis, Constantinos G ^a   Zuckerman, Steven H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

ACAT; Cholesterol efflux; Cholesterol ester; Foam cells; High density lipoprotein; Interferon

Indexed keywords

A 58035; APOLIPOPROTEIN E; ARACHIDONIC ACID; CD36 ANTIGEN; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; CHOLESTEROL ESTERASE; COLONY STIMULATING FACTOR; DOCOSAPENTAENOIC ACID; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANTIGENS, CD36; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; DNA PRIMERS; ENZYME INDUCTION; FOAM CELLS; HUMANS; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; STEROL O-ACYLTRANSFERASE;

EID: 0033985058     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
2. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362: 801-809.
3. Fuster, V., L. Badimon, J. J. Badimon, and J. H. Chesebro. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326: 242-250, 310-318.
4. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. P. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
5. Libby, P., Y. J. Geng, M. Aikawa, U. Schoenbeck, F. Mach, S. K. Clinton, G. K. Sukhova, and R. T. Lee. 1996. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7: 330-335.
6. Hansson, G. K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135: 169-175.
7. Geng, Y. J., J. Holm, S. Nygren, M. Bruzelius, S. Stemme, and G. K. Hansson. 1995. Expression of macropbage scavenger receptor in atherosclerosis: relationship between scavenger receptor isoforms and the T cell cytokine, interferon-γ. Arterioscler. Thromb. Vasc. Biol. 15: 1995-1202.
8. Li, H., M. I. Cybulsky, M. A. Gimbrone, and P. Libby. 1993. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13: 197-204.
9. Jonasson, L., J. Holm, O. Skalli, G. Gabiani, and G. K. Hanson. 1985. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76: 125-131.
10. Li, H., M. W. Freeman, and P. Libby. 1995. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 95: 122-133.
11. Oropeza, R., R. Schreiber, and Z. Werb. 1985. Regulation of apolipoprotein E expression in macrophages by γ-interferon. In Cellular and Molecular Biology of Lymphokines. C. Sorg and S. Schimpl, editors. Academic Press, Inc. New York. 303-307.
12. Brand, K., N. Mackman, and L. K. Curtiss. 1993. Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J. Clin. Invest. 91: 2031-2039.
13. LaMarre, J., B. B. Wolf, E. L. Kittler, P. J. Quesenberry, and S. L. Gonias. 1993. Regulation of macrophage α2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-γ. J. Clin. Invest. 91: 1219-1224.
14. Gupta, S., A. M. Pablo, X. C. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-γ potentiates atherosclerosis in apoE knockout mice. J. Clin. Invest. 99: 2752-2761.
15. Christen, S., S. R. Thomas, B. Garner, R. Stocker. 1994. Inhibition by interferon-γ of human mononuclear cell mediated low density lipoprotein oxidation: participation of tryptophan metabolism along the kynurenine pathway. J. Clin. Invest. 93: 2149-2158.
16. Geng, Y. J., and G. K. Hansson. 1992. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89: 1322-1330.
17. Havel, R. J., H. Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
18. Bieosbrioek, R. C., J. F. Oram, J. J. Alberts, and E. L. Bierman. 1983. Specific high affinity binding of HDL to cultured human skin fibroblasts and arterial smooth muscle cells. J. Clin. Invest. 61: 525-539.
19. Oram, J.F. 1986. Receptor mediated transport of cholesterol between cultured cells and high density lipoproteins. Methods Enzymol. 129: 645-659.
20. Mendez, A.J. 1997. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38: 1807-1821.
21. Petrichenko, I. E., D. Daret, G. V. Kolpakova, Y. A. Shakhov, and J. Larrue. 1997. Glucocorticoids stimulate cholesterol ester formation in human smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17: 1143-1151.
22. Cullen, P., M. Fobker, K. Tegelkamp, K. Meyer, F. Kanneberg, A. Cignarella, A. Benninghoven, and G. Assmann. 1997. An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl esters species by means of secondary ion mass spectrometry. J. Lipid Res. 38: 401-409.
23. Soares, M.B., M. De Fatima-Bonaldo, P. Jelene, L. Su, L. Lawton, and A. Efstratiadis. 1994. Construction and characterization of a normalized cDNA library. Proc. Natl. Acad. Sci. USA. 91: 9228-9232.
24. Mahley, R.W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
25. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann. 1994. A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA. 91: 1834-1838.
26. Ji, Y., B. Jian, N. Wang, Y. Sun, M. de la Llera Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
27. Calvo, D., D. Gomez-Coronado, Y. Suarez, M. A. Lasuncion, and M. Vega. 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL, J. Lipid Res. 39: 777-788.
28. de la Llera-Moya, M., G. H. Rothblat, M. A. Connely, G. Kellner-Weibel, S. W. Sakr, M. C. Phillips, and D. L. Williams. 1999. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J. Lipid Res. 40: 575-580.
29. Nakagawa, T., S. Nozaki, M. Nishida, J. M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, S. Yamashita, and Y. Matsuzawa. 1998. Oxidized LDL increases and interferon-gamma decreases expression of CH36 in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025.
30. Kritharides, L., A. Christian, G. Stoudt, D. Morel, and G. H. Rothblat. 1998. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler. Tromb. Vasc. Biol. 18: 1589-1599.
31. Brown, M., and J. Goldstein. 1980. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255: 9344-9352.
32. Boehm, U., T. Clamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
33. Zuckerman, S. H., G. F. Evans, and L. O'Neal. 1992. Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-β. Atherosclerosis. 96: 203-214.
34. Jonasson, L., G. K. Hansson, G. Bondjers, L. Noe, and J. Etienne. 1990. Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim. Biophys. Acta. 1053: 43-48.
35. Fielding, C. J. 1992. Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J. 6: 3162-3168.
36. Warner, G. J., G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat. 1995. Cell toxicity induced by inhibition of acyl coenzyme A cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270: 5772-5778.
37. Jepson, C. A., and S. J. Yeaman. 1993. Expression of hormone-sensitive lipase in macrophage foam cells. Biochem. Soc. Trans. 21: 2325.
38. Schmitz, G., R. Niemann, B. Brennhausen, R. Krause, and G. Assmann. 1985. Regulation of high density lipoprotein receptors in cultured macrophages: role of actyl-CoA:cholesterol acyltransferase. EMBO J. 4: 2773-2779.
39. Mendez, A. J. 1995. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol-enriched cells. J. Biol. Chem. 270: 5891-5900.
40. Wang, H., S. Germain, P. Benfield, and P. Gillies. 1995. Gene expression of acyl coenzyme A. Arterioscler Thromb. Vasc. Biol. 16: 809-814.
41. Cheng, W., K. V. Kvilekval, and N. A. Abumrad. 1995. Dexamethasone enhances accumulation of cholesteryl esters in human macrophages. Am. J. Physiol. 269: E642-648.
42. Chang, T. Y., C. C. Chang, and D. Cheng. 1997. Acyl-coenzyme A: cholesterol acyltransferase. Annu. Rev. Biochem. 66: 613-638.
43. Uelmen, P. J., K. Oka, M. Sullivan, C. C. Chang, T. Y. Chang, and L. Chan. 1995. Tissue-specific and cholesterol regulation of acylcoenzyme A: cholesterol acyltransferase (ACAT) in mice. J. Biol. Chem. 270: 26192-26201.
44. Cases, S., S. Novak, Y. W. Zheng, H. M. Myers, S. R. Lear, E. Sande, C. B. Welch, A. J. Lusis, T. A. Spencer, B. R. Krauser, S. K. Erickson, and R. V. Farese. 1998. ACAT-2, a second mammalian acylcoA:cholesterol acyltransferase. J. Biol. Chem. 273: 26755-26764.
45. Anderson, R. A., C. Joyce, M. Davis, J. W. Reagan, M. Clark, G. S. Shelness, and L. L. Rudel. 1998. Identification of a form of acylcoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273: 26747-26754.
46. Meiner, V. L., S. Cases, H. M. Myers, E. R. Sande, S. Bellosta, M. Schambelan, R. E. Pitas, J. McGuire, J. Herz, and R. V. Farese. 1996. Disruption of the acyl-coA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA. 93: 14041-14046.
47. Pape, M. E., P. A. Schultz., T. J. Rea, R. B. DeMattos, K. Kief, C. L. Bisgaier, R. S. Newton, and B. R. Krause. 1995. Tissue specific changes in acyl-CoA:cholesterol acyltransferase (ACAT) mRNA levels in rabbits. J. Lipid Res. 36: 823-838.
48. Miyazaki, A., N. Sakashita, O. Lee, K. Takahashi, S. Horiuchi, H. Hakamata, P. Morganelli, C. C. Chang, and T. Y. Chang. 1998. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. 18: 1568-1574.